POPULARITY
Recordamos a Maribel Toyos, ex presidenta de la Federación asturiana de Squash, fallecida recientemente. Entrevistamos a la flamante campeona del Dakar en motos, Sandra Gómez Cantero. Iniciamos con la FDNA un repaso por las nuevas federaciones asturianas conociendo a las mujeres de la natación asturiana con la vocal de la mujer Irene Carriles. Y para cerrar recordamos con Vero Castro a Agnes Keleti, la campeona olímpica más longeva que ha fallecido a una semana de cumplir 104 años.
Integrating AI in healthcare with special focus on genetics https://outcomesrocket.health/fdna/2019/09/
A computer algorithm can now identify genetic abnormalities from photos, enabling physicians to shorten the diagnostic odyssey by quickly identifying children with rare diseases. The founders sold their first facial recognition business to Facebook and are now trying to do something more meaningful. David suggests turning the algorithm on John to see what’s wrong with him. Watch this episode on YouTube: https://youtu.be/KlXzwBY6Wo4
Ilana Jacqueline is a best-selling author, speaker, patient advocacy strategist, and professional patient advocate. While her background is in PR, her career as a patient advocate started with an early blog, Let’s Feel Better, in 2012, and gave birth to the book Surviving and Thriving with an Invisible Chronic Illness – which was Lauren’s playbook when she first got diagnosed (Ilana has a way of saying it like it is and managing to stay sane and amused that is right up Lauren’s alley). She has a longstanding relationship with Global Genes, where she served as the managing editor of The RARE Daily for five years. She was later appointed the Manager of Patient Advocacy at FDNA, where she developed the Genomics Collaborative program. Most recently, she has joined the boards of RUN (Rare and Undiagnosed Network), HAS (Health Advocacy Summit), and IDA (Invisible Disabilities Association), while also working at WEGO Health and continuing her regular column in IG Living. She has a long career of freelance writing, and has contributed to publications including The Huffington Post, Marie Claire, Everyday Health, Mashable, and The Miami Herald, among others. She speaks at medical, patient, and pharma conferences as well as consulting with companies on how the patient voice can improve the design of healthcare. Tune in as Ilana shares… - all about Surviving and Thriving with an Invisible Chronic Illness - about life with PIDD (Primary Immune Deficiency Disease) - that her family is more holistic when it comes to healing – but that holistic approaches haven’t been effective in managing all her symptoms - that she’s eager to try varied approaches to her healthcare - how difficult it was to be taken seriously by doctors - that she lives with constant gastrointestinal issues, nausea, etc. - what PIDD is: a lack of antibodies to prevent illness; and how to treat it: intravenous immunoglobulin therapy (IVIG) - that she is one of the very rare few living with PIDD who do not have a positive response to IVIG – so now, she treats infections as they come (high-dose/IV antibiotics, etc.) - that she has survived pneumonia, sepsis, and other serious conditions as a result of PIDD - that she is constantly proactive about her health, prevention, and care - how telecommuting has enabled her to have a career without endangering her body - the role that self-care and boundaries play in her life, both personally and professionally - confrontations with strangers – and the audacity of the uninformed - what it was like to have a visible element to her chronic illness (in the form of a central or PICC line) - the “rite of passage” of being judged for using the disabled spot in a parking lot – when you have a parking pass and live with disability, but look young and able - why she’s solution-focused and doesn’t wallow in sadness - her “curiosity cards” – business cards that called strangers out on staring, and provided answers through her blog - escaping uncomfortable situations without always engaging - why it’s not a disabled/chronically ill person’s responsibility to educate everyone – but why instructing the public on how to respond is useful - her co-morbidities, among them dysautonomia (the dysfunction of the autonomic nervous system) – and why hydration and fluids are so important to her health - how her mom has shown up as her advocate – and discovered her own diagnoses after Ilana did - how she’s learned to mitigate medical trauma - how her husband has taken on the role of advocate from the beginning of their relationship - what it’s like to be a patient advocate - her realizations about friendship with chronic illness – and that relationships are a two-way street - other chronic illness warriors she admires - how she was diagnosed with pelvic floor dysfunction - the thin line between empowerment and shame in the chronic illness world - the importance of finding a good therapist
Integrating AI in healthcare with special focus on genetics
If you’ve been to a medical facility recently, you may have already had some of your healthcare provided for you by AI. Massive amounts of raw medical data have been compiled since medical imaging hit the scene, and with computing power up to the task, it can now be harnessed in novel, fascinating ways: diagnosing life-threatening diseases, plus assessing risk of disease and pregnancy complications. And that’s just the start. With any new technology comes risk: More data can improve diagnosis, treatment, healthcare and operational efficiency, but sensitive data requires stringent security measures. It’s one thing if someone steals your credit card … quite another altogether if someone steals your DNA. Data scientists and security experts are working tirelessly to make sure AI’s arrival into the medical arena is a seamless, secure one. Host Jessica Chobot checks in for a checkup and is joined on her wellness journey by Dave Graham of Dell Technologies, Eran Orr, Founder & CEO of AR/VR health startup XR Health, Dekel Gelbman of Boston biotech firm FDNA, and Joe Marks, Executive Director of the Center for Machine Learning and Health at Carnegie-Mellon University. Can fully autonomous AI replace doctors, nurses, clinicians and surgeons? Will AI give Jessica a clean bill of health? Find out in this episode of Hype v. Reality. And head to our YouTube channel to watch Jessica's VR session.
Harry's guest is Dekel Gelbman, founding CEO of FDNA. The company uses a combination of computer vision, deep learning, and other artificial intelligence techniques to improve and accelerate diagnostics and therapeutics for children with rare diseases. How to rate MoneyBall Medicine on iTunes with an iPhone, iPad, or iPod touch: Launch the "Podcasts" app on your device. If you can't find this app, swipe all the way to the left on your home screen until you're on the Search page. Tap the search field at th top and type in "Podcasts." Apple's Podcasts app should show up in the search results. Tap the Podcasts app icon, and after it opens, tap the Search field at the top, or the little magnifying glass icon in the lower right corner. Type MoneyBall Medicine into the search field and press the Search button. In the search results, click on the MoneyBall Medicine logo. On the next page, scroll down until you see the Ratings & Reviews section. Below that you'll see five purple stars. Tap the stars to rate the show. Scroll down a little farther. You'll see a purple link saying "Write a Review." On the next screen, you'll see the stars again. You can tap them to leave a rating, if you haven't already. In the Title field, type a summary for your review. In the Review field, type your review. When you're finished, click Send. That's it, you're done. Thanks!
For the inaugural episode of Artificial Intelligence in Drug Discovery, I spoke with Dekel Gelbman, CEO of FDNA ( https://www.fdna.com/ ). FDNA enables precision medicine by using artificial intelligence for next-generation phenotyping. Their technology links genetic traits with phenotypic characteristics such as facial structure. Listen now to learn what inspired the technology, the problems it solves, how it can help in the drug discovery process, and where FDNA plans to take it. This episode is brought to you by BenchSci ( https://www.benchsci.com ). BenchSci uses artificial intelligence to reduce the cost of scientific experiments. Use it to find research antibodies up to 24x faster than using PubMed or Google Scholar. Just enter a protein of interest and filter by technique, organism, tissue, or 12 other options. BenchSci returns only relevant published figures and products. It’s free for academic researchers. Work in industry? Request a demo at https://www.benchsci.com.
Harnessing the power of computers to diagnose rare, genetic diseases is not new idea, but Dekel Gelbman is using Big Data to analyze a patient’s phenotype as a clue to his or her genotype. His company FDNA has developed Face2Gene, a platform for analyzing an image of a patient’s face to help arrive at a diagnosis. We spoke to Gelbman about the challenges of diagnosing a rare disease, how Face2Gene works, and why it could accelerate the process of getting a diagnosis.